Squarepoint Ops LLC Axogen, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 29,815 shares of AXGN stock, worth $484,791. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,815

Previous 60,913 51.05%

Holding current value

$484,791

Previous $441,000 5.22%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.52 - $14.69 $233,856 - $456,829	-31,098 Reduced 51.05%	29,815 $418,000
Q2 2024 Aug 14, 2024	BUY	$5.67 - $8.06 $224,668 - $319,369	39,624 Added 186.12%	60,913 $441,000
Q1 2024 May 15, 2024	SELL	$6.63 - $10.69 $398,177 - $642,009	-60,057 Reduced 73.83%	21,289 $171,000
Q4 2023 Feb 14, 2024	BUY	$3.61 - $7.76 $117,126 - $251,773	32,445 Added 66.35%	81,346 $555,000
Q2 2023 Aug 14, 2023	BUY	$8.5 - $10.38 $145,503 - $177,684	17,118 Added 53.86%	48,901 $446,000
Q1 2023 May 15, 2023	BUY	$7.53 - $10.95 $99,697 - $144,978	13,240 Added 71.4%	31,783 $300,000
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $39,572 - $54,873	4,192 Added 29.21%	18,543 $185,000
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $116,817 - $175,799	14,351 New	14,351 $171,000
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $136,633 - $195,470	-19,547 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.26 - $10.7 $103,854 - $153,063	-14,305 Reduced 42.26%	19,547 $155,000
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $297,897 - $541,632	33,852 New	33,852 $317,000
Q3 2021 Nov 15, 2021	SELL	$15.23 - $21.72 $236,598 - $337,420	-15,535 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $276,523 - $365,072	15,535 New	15,535 $336,000
Q1 2021 May 17, 2021	SELL	$17.18 - $22.6 $370,246 - $487,052	-21,551 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.5 - $17.96 $41,354 - $64,584	3,596 Added 20.03%	21,551 $386,000
Q3 2020 Nov 16, 2020	BUY	$10.62 - $13.12 $77,005 - $95,133	7,251 Added 67.74%	17,955 $209,000
Q2 2020 Aug 14, 2020	SELL	$7.35 - $10.81 $62,680 - $92,187	-8,528 Reduced 44.34%	10,704 $99,000
Q1 2020 May 15, 2020	BUY	$8.38 - $17.34 $161,164 - $333,482	19,232 New	19,232 $200,000
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $444,912 - $752,928	-36,800 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $72,002 - $99,129	3,892 Added 11.83%	36,800 $729,000
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $101,199 - $153,183	-6,922 Reduced 17.38%	32,908 $693,000
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $532,011 - $1.19 Million	31,130 Added 357.82%	39,830 $814,000
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $149,207 - $244,953	-4,382 Reduced 33.5%	8,700 $321,000
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $2,964 - $4,305	82 Added 0.63%	13,082 $657,000
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $302,730 - $499,381	-12,407 Reduced 48.83%	13,000 $475,000
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $277,796 - $429,457	15,016 Added 144.51%	25,407 $719,000
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $152,228 - $201,065	10,391	10,391 $201,000

Others Institutions Holding AXGN

# of Institutions

162

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $688M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Axogen, Inc. Transaction History